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We have identified a synthetic peptide derived from the BZ-chain of mouse laminin, Arg-Asn-Ile-Ala-Glu-Ile-Ile-Lys-Asp- 
Be (p20), which simulates the neurite outgrowth-promoting activity of the native molecule. In organotypic cultures, neu- 
rons from newborn mouse brain or embryonic peripheral nervous system responded by extensive neurite outgrowth for 
native laminin or the peptide p20 in the culture medium. If rat cerebellar neurons were grown on laminin, l-5 FM (l-5 
pg/ml) of peptide p20 in the culture medium competed with laminin and inhibited neuronal attachment and neurite out- 
growth, whereas higher concentrations (> 50 FM; > 50 pg/ml) had a specific neurotoxic effect. When peptide p20 was 
used as the culture substratum, neurite outgrowth in cerebellar cultures was up to 60% of that seen on native laminin. 
Our results indicate that a neurite outgrowth-promoting domain of laminin is located in the a-helical region of the 
BZ-chain, and is active for both central and peripheral neurons. 
Laminin; Neurite outgrowth; Synthetic pcptide 
1. INTRODUCTION 
Laminin is a 1000 kDa extracellular matrix pro- 
tein and a basement membrane component [1,2] 
that has a multidomain structure with various 
functions [3-S]. Recent evidence suggests that 
apart from its structural role in basement mem- 
branes, laminin or laminin-like molecules [6,7] 
may play a role in brain development [B-l 11 and 
nerve regeneration [ 12- 151. Studies using 
monoclonal antibodies to proteolytic fragments of 
laminin have suggested that the neurite outgrowth- 
promoting domain of laminin may be near or in 
the heparin-binding region of the molecule 
[ 16- 181. Proteolytic fragments isolated from this 
area have further been shown to promote attach- 
ment of chicken peripheral neurons [ 16,181. Since 
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the general cell-attachment domain of laminin has 
been mapped to the Pl-fragment of the molecule 
[19] and has recently been shown to lie in the 
Bl-chain of the protein [20], it is possible that 
laminin has multiple sites for cell attachment as 
well as for neurite outgrowth. This view is sup- 
ported by the presence of more than one receptor 
molecule for laminin [21-261. 
In this paper, we identify a region in the 
B2-chain of mouse laminin, Arg-Asn-Ile-Ala-Glu- 
Ile-Ile-Lys-Asp-Be, that has characteristics for a 
putative neurite outgrowth-promoting domain of 
laminin. This can be concluded since nanomolar 
concentrations of synthetic peptides derived from 
this region simulate the neurite outgrowth function 
of native laminin. 
2. MATERIALS AND METHODS 
2.1. Peptide synthesis and coupling to carrier proteins 
Peptides were synthesized by the solid-phase method [27] us- 
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ing a Vega Copier (250C) peptide synthesizer and r-Boc 
chemistry. The additional Gly-Cys in the carboxy-terminal was 
added to facilitate coupling of the peptides to carrier proteins. 
The sequences of the purified peptides were confirmed with gas- 
phase sequencer (model 470 A, Applied Biosystems). Peptide 
~20, RNIAEIIKDI (GC), and peptide p3 1, CDPGYIGSR(GC), 
were coupled to bovine serum albumin (BSA, Sigma, St. Louis, 
MO) via the carboxy-terminal cysteine as described (281. Using 
this procedure approx. 20 peptide molecules were attached to 
one albumin molecule. The concentrations of albumin coupled 
peptides were always indicated according to the concentration 
of the peptide. The BSA-coupled peptides were used in cell- 
attachment studies only. In all other experiments uncoupled 
free peptides were applied. 
2.2. Organotypic ultures 
In Trowell-type organotypic cultures, newborn mouse spinal 
cord and cerebellum or 16-day-old mouse embryo dorsal root 
ganglia (DRG) were grown on Nuclepore filters (pore size 
1 .O pm; Pleasanton, CA) placed on a metal grid in a serum free, 
chemically defined NI-medium [29] with or without one of the 
following peptides in the culture medium: ~20, p3 1, ~32, P6 or 
P7 (see table 1). All peptides were used at 100 nM (0.1 pg/ml). 
In DRG cultures the medium also contained 10 nM of 7S-NGF 
(Collaborative Research, Lexington, MA). In some ex- 
periments, the cultures were grown in the presence of soluble 
native mouse laminin, also applied at 100 nM (lOOpg/ml). 
After 24-48 h the cultures were fixed with cold (-20°C) 
methanol for 30 mitt, the tissue explant was scraped off and the 
filters were exposed to rabbit polyclonal antibodies to 
neurofilament proteins [30] for 24 h at 4°C as described [31]. 
2.3. Survival and competition assays 
Glass coverslips were covalently coupled [32] with 100 pg/ml 
of purified mouse laminin [2]. The free peptides were usually 
added to the culture medium simultaneously with the cells that 
were mechanically dissociated from newborn rat (Wistar) 
cerebellum [3 11. In survival studies the peptides were applied at 
lOOag/ml and in competition assays at concentrations of 
l-5 Fg/ml. In time-lapse-video recording experiments, 
50 pg/ml of peptide p20 was added to neurons that had already 
extended neurites on laminin. Time-lapse-video recordings were 
performed using a National NV-8030 time-lapse recorder in- 
stalled with an Olympus IMT inverted research microscope with 
high magnification oil-immersion optics. 
2.4. Cell attachment and neurite outgrowth assays 
Glass coverslips were covalently coupled with lOOpg/ml 
(100-200 nM) of the peptides p20-BSA and p31-BSA alone or 
in combinations indicated. Cells from newborn rat (Wistar) 
cerebellum were mechanically dissociated [31], and plated on 
the coverslips at a density of 1 x lO’/ml in the NI-medium [29]. 
Quantitation of attached neurons and their neurite extension 
was performed after 24 h by counting all live attached neurons 
with long neurites (> 5 times cell soma) using P Leitz Labovert 
inverted microscope with phase-contrast optics. In these ex- 
periments, the entire 18 mm coverslip was screened, and all 
single live neurons counted. In each experiment 4-5 coverslips 
per each culture substrate were screened, and the arithmetical 
mean of attached neurons with neurites on laminin substrate in 
one experiment was considered to be 100% and the means on 
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all the remaining substrates of that experiment compared with 
it. The total of six separate experiments (see above) formed the 
raw material of the figures. 
3. RESULTS 
3.1. Neurite outgrowth-promoting activity of 
soluble laminin and peptide p20 in 
organotypic cultures 
Explants of newborn mouse spinal cord, 
cerebellum and embryonic DRG extended short 
neurites through the pores of the Nuclepore filter 
within 24 h (fig.lA,C,E). In the presence of 
100 nM (0.1 ,ug/ml) of the free peptide p20 (see 
table 1) or its longer derivative p32 (see table l), 
both spinal cord and cerebellar neurons showed ex- 
tensive neurite outgrowth through the pores of the 
filter (fig.lB,D). Neurite outgrowth in the DRG 
cultures was also stimulated, but the response was 
less dramatic (fig. 1F). Higher concentrations of 
peptide p20 (up to 100 pg/ml) did not improve the 
neurite-outgrowth response, nor do they inhibit it. 
The non-neuronal cell-attachment decapeptide of 
laminin (~31; see table 1) or other control peptides 
tested (P6, P7; see table 1) had no effect on neurite 
outgrowth in this culture system. If 100 nM 
(100 pg/ml) of native laminin was included in the 
culture medium, neurite outgrowth through the 
pores of the filter was comparable to that seen in 
the presence of peptide p20 (fig.lG). 
3.2. Neurite outgrowth of neurons on laminin in 
the presence of synthetic peptides in the 
culture medium 
3.2.1. Neuronal survival 
If newborn rat cerebellar neurons or mouse em- 
bryo DRG were plated on laminin coated glass 
coverslips, long neurites extended within 12 h 
(fig.2a,c). Addition of 100 ,uM (100 pg/ml) of pep- 
tide p20 or its longer derivative ~32, simultaneous- 
ly with the cells, resulted in neuronal death within 
12 h (fig.2b), and neurite outgrowth in the DRG 
cultures was inhibited (fig.2d). A time-lapse-video 
recording revealed that addition of 50 pg/ml of 
peptide p20 to the culture medium of neurons that 
had already extended neurites on laminin caused 
complete cessation of cytoplasmic streaming and 
movement of the growth cones and ruffling mem- 
branes within 2 h exposure to peptide p20 (not 
shown). The inhibitory effect of the peptide for 
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Fig.1. Demonstration of neurofilament protein immunoreactivity in organotypic cultures of newborn mouse spinal cord (A.B), 
cerebellum (C,D,G) and 16-day-old mouse embryo DRG (E,F). The fibres grown through the filter in 24 h are demonstrated in the 
absence (A,C,E) or in the presence (B,D,F) of 100 ng/ml (100 nM) of peptide p32 or laminin (G) in the culture medium. The presence 
of peptide p32 or laminin stimulated outgrowth of neurites in all areas (cf. A,C,E with B,D,F,G). In cultures of DRG (F) the effect 
of peptide p32 was less dramatic than with central neurons. Bar = 20/m. 143 
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P-l KAKDEMKASD” [33,34] - 
P20 RNIAEIIKDIGCb [33,34] +++ 
neuronal survival was dose dependent (fig.3) and 
specific for primary neurons. No toxicity was 
observed even with 200 pg/ml(O.2 mM) of peptide 
p20 for primary glial cells or for differentiation of 
1 l-day-old mouse embryo kidney (not shown). The 
non-neuronal cell-attachment peptide p3 1 [20] or 
the other seven peptides tested (see table 1) did not 
influence neuronal survival on laminin when ap- 
plied at similar concentrations (up to 200 ,ug/ml; 
P31 CDPGYIGSR [20] _ 
P32 KQEAAIMDYNRNIAEIIKDIHNLED- 
IKKTLb +++ 
a In our earlier work [41] this sequence was found to be 
neurotoxic at lOO&mI. Further analysis and improved 
peptide synthesis methods, however, showed that the peptide _ _ 
was inactive, and its neurotoxicity was due to impurities in the 
and, 
peptide preparation 
b Four separate patches of peptide p20 were synthesized to
thus, detected its non-toxic neurite outgrdwth 
confirm the reproducibility of its effects on eurons. Due to 
stimulating effects 
our earlier experience we lowered the concentrations of ~20, 
The laminin peptides were d rived from the cDNA sequence of 
table 1). 
3.2.2. Competition assays 
Rat cerebellar neurons were plated on laminin 
substrate and the free peptide p20 was 
simultaneously included into the culture medium 
at concentrations below the toxicity range (e.g., 
l-5 pg/ml; l-5 PM; see fig.3). Under these condi- 
tions, the attachment of neurons to laminin was 
reduced down to 5570% of that seen on native 
laminin (fig.4), and outgrowth of long neurites was 
inhibited down to 20-40% of that seen on native 
laminin (fig.4). 
the mouse B2-chain [33,34], and their relation to the domain 
map of laminin was presented as a diagram. It is notable that 
the sequence of the BZ-chain of human laminin [36] is slightly 
different from that of the mouse in the area of peptide ~20 
A 
c. 
1 \ 
‘f’ 
1 
_‘_ .
I \ 
p31 ‘y’ 
3.3. Attachment and neurite outgrowth of central 
neurons on synthetic peptides 
Rat cerebellar neurons were plated on glass 
coverslips coated with the peptides p20-BSA 
and/or p3 1 -BSA at 100-200 nM (100-200 ng/ml), 
e.g. the equimolar concentration for 
100-200 pug/ml (100-200 nM) of native laminin. 
BSA substratum was used as a control at a concen- 
tration of 600 ng/ml, which equals the BSA con- 
centration of the peptide conjugates used at 
200 ng/ml. The peptide p20-BSA (200 ng/ml) 
alone supported neuronal attachment nearly as 
well as the peptides p20-BSA (100 ng/ml) and 
144 
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Fig.2. Phase-contrast micrographs of newborn rat cerebellar (a,b) and 16-day-old mouse embryo dorsal root ganglia (c,d) neurons 
grown on Iaminin in the absence (a,b) or in the presence (b,d) of 1OOpg/ml(lOO JAM) of peptide ~20. Neurons showed extensive neurite 
outgrowth on Iaminin (a,c, arrows). In the presence of 100 pg/ml of the peptide p20 (or ~32) massive cell death occurred (b) and all 
neurite outgrowth was inhibited (d, arrow). Bar = 40/m. 
p31-BSA (100 ng/ml) used simultaneously as 
culture substratum (cf. p20 with p20 + p31 in 
fig.5). Outgrowth of neurites on p20-BSA alone 
(~20 in fig.5) was up to 60% of that seen on native 
laminin, and was comparable to the neurite 
outgrowth when the peptides p20-BSA and 
p3 1 -BSA were used simultaneously (see p20-p3 1 in 
fig.5). Peptide p31-BSA (200 ng/ml; ~31 in fig.5) 
alone supported attachment of neurons, but its ef- 
fect on outgrowth of neurites was only marginally 
better than that of albumin (cf. BSA and ~31 in 
fig.5). 
4. DISCUSSION 
We have identified a region in the B2-chain of 
mouse laminin, Arg-Asn-Ile-Ala-Glu-Ile-Ile-Ly~- 
Asp-Ile (p20), which bears the criteria for a neurite 
outgrowth-promoting domain for primary central 
and peripheral neurons. This can be concluded, 
145 
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Fig.3. A dose-response curve for the effect of peptide p20 added 
to the culture medium on the number of neurons (H) and 
neurites (IXI) in cultures of newborn rat cerebellum grown on 
laminin. Concentrations higher than 50 pg/ml caused a specific 
neurotoxic effect, whereas concentrations of l-5 pg/ml were 
non-toxic. 
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Fig.4. Attachment of neurons (u) and outgrowth of neurites 
) in cultures of rat cerebellar neurons grown on laminin in 
the presence of l-5 pM (l-5 pg/ml) of the free peptide p20 in 
the culture medium after 12 h in vitro. Both neuronal 
attachment and neurite outgrowth on laminin are inhibited. The 
most clearcut effect is the ability of peptide p20 (5 Fg/ml) to 
inhibit outgrowth of neurites on the laminin substrate down to 
30% of that seen on laminin. 
since nanomolar (100-200 nM) concentrations of 
this peptide promote neurite outgrowth of central 
and peripheral neurons in organotypic cultures; 
compete with laminin for both neuronal attach- 
ment and neurite outgrowth; and simulate the ef- 
fect of laminin when coupled to albumin and 
% 60 
40 
20 
0 
LAM BSA P20 P31 p2O+p31 
Fig.5. Neuronal attachment (m) and number of neurites ( 
cultures of rat cerebellar neurons grown on LAM (100 fig/ml), 
BSA (0.6 ,ug/ml), p20-BSA (0.2 pg/ml), p31-BSA (0.2 tg/ml) 
or p20-BSA + p3 I-BSA (0.1 pg/ml each). The peptide p20-BSA 
alone was comparable in neuronal attachment and neurite 
outgrowth to the two peptides p20-BSA and p31-BSA together 
(~20 + 31). The peptide p31-BSA (~31) alone did not support 
neurite outgrowth any better than albumin, although it 
supported attachment of neurons. 
included into the culture substratum. The decapep- 
tide (~20) sequence was selected from the cDNA 
sequencing data available [33,34]. This sequence 
was chosen because it represented the amphiphilic 
peak [35] of the region of mouse laminin known to 
promote neurite outgrowth 116,181. A closely 
related, but not identical sequence is present in the 
B2-chain of human laminin [36] and its effect in 
promoting neurite outgrowth of mouse or human 
neurons remains to be investigated. 
We found that laminin and equimolar concen- 
trations of the peptide ~20, derived from the 
B2-chain of mouse laminin, support neurite 
outgrowth of central and peripheral neurons in 
organotypic cultures. This suggests that soluble 
laminin or peptide p20 may act as a stronger at- 
tractant for neurite outgrowth than the laminin 
present in the tissue explant itself. Since 
nanomolar concentrations of soluble laminin have 
been detected in the cerebrospinal fluid of adult 
mice [37], it is possible that laminin and/or soluble 
peptides, e.g. the neurite outgrowth-promoting 
peptide, may be released by the proteolytic 
machinery of the brain and exert functional or 
pathological response. 
The ability of peptide p20 to simulate the effect 
of laminin at physiological concentrations and its 
specific neurotoxicity at high concentrations are of 
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Volume 244, number 1 FEBS LETTERS February 1989 
particular interest, since they indicate that this se- 
quence is specifically active for neurons. It is not 
possible to test, whether equimolar amounts of 
soluble laminin would be similarly neurotoxic, 
because this would require concentrations 
(0.1 g/ml; 100 mM) of laminin that would not re- 
main in solution. Since insulin and many 
substances that have a biological function at 
physiological concentrations are toxic at high con- 
centrations, a similar situation might be obtained 
in our experiments with peptide ~20. Competition 
for neuronal attachment and neurite outgrowth 
with laminin suggests that the amino acid sequence 
of peptide p20 may be recognized by neuronal 
laminin receptors. Although this peptide sequence 
was chosen for its amphiphilicity and not for its 
hydrophilicity like the fibronectin [38] or laminin 
[20] cell-attachment peptides, the function of this 
region may be analogous to that of the fibronectin 
cell-attachment sequence, known to compete with 
fibronectin for fibroblast attachment and receptor 
binding [38]. The fact that the concentrations of 
the fibronectin tetrapeptide, effective in competi- 
tion assays for fibroblast attachment [38], were 
higher than those of peptide ~20, effective in our 
competition assay, may reflect the higher sensitivi- 
ty of the non-dividing neurons as opposed to the 
fibroblasts. 
Is the sequence of peptide p20 the only neuronal 
attachment and neurite outgrowth-promoting do- 
main of laminin? If this were the case one would 
expect peptide p20 to substitute laminin complete- 
ly. This is clearly not the case. As culture 
substratum, the peptide p20-BSA alone or together 
with the non-neuronal cell-attachment peptide 
(p31-BSA) simulated the effect of laminin, but 
could never fully substitute the native protein. 
Similarly, lo-50-fold molar excess of peptide p20 
in the culture medium of neurons plated on 
laminin, did compete with the native protein, but 
inhibition of neurite outgrowth was not complete. 
Since laminin is such a large molecule its different 
chains may exert different effects on neurons, and 
interaction of several domains with each other or 
with other cell surface molecules may be needed 
for neuronal survival and maximal neurite 
outgrowth. This view is also supported by earlier 
work that has provided evidence for the role of the 
A-chain of laminin in promotion of neurite 
outgrowth 1161, and by recent results that further 
imply that a 25 kDa proteolytic fragment of 
laminin, bearing both the region identified in this 
paper and the area reported by Engvall et al. [17], 
is capable of supporting attachment and neurite 
outgrowth of chicken peripheral neurons [18]. 
In previous studies, the non-neuronal cell- 
attachment domain of laminin has been localized 
in the P 1 -fragment of the molecule [ 191. Using syn- 
thetic peptides Graf et al. [20] have recently 
demonstrated that the function of this domain 
could be substituted by a synthetic peptide from 
the Bl-chain of laminin included within the 
Pl-fragment. These authors further reported that 
their peptide sequence supported neuronal attach- 
ment, but no neurite outgrowth. Our results cor- 
roborate this work, since physiological 
concentrations of the peptide p31-BSA alone sup- 
ported attachment of neurons, but did not pro- 
mote outgrowth of neurites any better than BSA. 
Since the peptides p20-BSA and p31-BSA together 
did not fully simulate the effect of native laminin, 
and were not essentially any better than the peptide 
p20-BSA alone in promoting neurite outgrowth, 
the effect of p31-BSA may be indirect and due to 
its growth factor-like properties [20]. 
Future work in this laboratory aims at 
characterizing the intermolecular interactions and 
co-operation between different domains of laminin 
that may be necessary to support neuronal 
development and survival. Synthetic peptides and 
their antibodies may be utilized in this approach, 
since our present results indicate, that a domain of 
laminin responsible for neurite outgrowth and 
neuronal attachment is largely independent of the 
tertiary structure or carbohydrate substitution of 
the native protein. 
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